dpp-4 inhibitors vs. glp-1 agonist Role of Dipeptidyl Peptidase 4 in Antidiabetic Treatment Dipeptidyl peptidase 4 inhibitors in

10 The American College of Cardiology/American Heart Association primary prevention of cardiovascular disease guideline supports the use of GLP-1 RAs in patients with T2D and high atherosclerotic CVD risk, but does not mention existing HF

If nausea from your medication has cut into how much you're eating and drinking overall, add a pinch of sea salt or an electrolyte packet to improve absorption

Furthermore, the growing R&D and faster regulatory approvals are also increasing their innovations, which are supported by healthcare investments

2025 Apr 2;10(6):1980-1992

In recent years, GLP-1 medications have become a focal point in the medical community due to their innovative treatment mechanisms, significant therapeutic efficacy, and broad development prospects